These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6502175)

  • 41. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P; Batir A; Van Blercom N; Chabardes S; Fraix V; Ardouin C; Koudsie A; Limousin PD; Benazzouz A; LeBas JF; Benabid AL; Pollak P
    N Engl J Med; 2003 Nov; 349(20):1925-34. PubMed ID: 14614167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age influences magnitude but not duration of response to levodopa.
    Durso R; Isaac K; Perry L; Saint-Hilaire M; Feldman RG
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):65-8. PubMed ID: 8429325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dementia and treatment with L-dopa in Parkinson's disease.
    Hietanen M; Teräväinen H
    Mov Disord; 1988; 3(3):263-70. PubMed ID: 3193964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognition in a patient with very mild right-sided hemiparkinsonism.
    Beatty WW
    Neurocase; 2002; 8(1-2):28-39. PubMed ID: 11997483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different cognitive profiles on standard behavioral tests in Parkinson's disease and Alzheimer's disease.
    Sullivan EV; Sagar HJ; Gabrieli JD; Corkin S; Growdon JH
    J Clin Exp Neuropsychol; 1989 Dec; 11(6):799-820. PubMed ID: 2592525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive slowing in Parkinson's disease resolves after practice.
    Press DZ; Mechanic DJ; Tarsy D; Manoach DS
    J Neurol Neurosurg Psychiatry; 2002 Nov; 73(5):524-8. PubMed ID: 12397144
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of clinical motor variables and medication dosage on working memory in Parkinson's disease.
    Moustafa AA; Bell P; Eissa AM; Hewedi DH
    Brain Cogn; 2013 Jul; 82(2):137-45. PubMed ID: 23660434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure of psychomotor functions in parkinsonian patients during long-term treatment.
    Jacobi P; Fischer PA; Schneider E
    Adv Neurol; 1984; 40():279-83. PubMed ID: 6695604
    [No Abstract]   [Full Text] [Related]  

  • 49. Anxiety and motor performance in Parkinson's disease.
    Siemers ER; Shekhar A; Quaid K; Dickson H
    Mov Disord; 1993 Oct; 8(4):501-6. PubMed ID: 8232361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and electromyographic examinations on the effect of hydrochloride (Viregyt-K) in the treatment of Parkinson's disease.
    Schubert U; Fischer GJ; Glass J
    Ther Hung; 1977; 25(2):55-63. PubMed ID: 898119
    [No Abstract]   [Full Text] [Related]  

  • 51. [Age-related working memory decline in patients with Parkinson's disease].
    Tamura I; Kikuchi S; Kitagawa M; Otsuki M; Tashiro K
    No To Shinkei; 2003 Apr; 55(4):335-40. PubMed ID: 12755037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A retrospective analysis of the effects of anticholinergic medication on memory performance in Parkinson's disease.
    Levin BE; Llabre MM; Reisman S; Weiner WJ; Brown MC
    J Neuropsychiatry Clin Neurosci; 1991; 3(4):412-6. PubMed ID: 1821262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Source memory in Parkinson's disease.
    Hsieh S; Lee CY
    Percept Mot Skills; 1999 Oct; 89(2):355-67. PubMed ID: 10597569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Procedural memory in recent-onset Parkinson's disease.
    Thomas-Ollivier V; Reymann JM; Le Moal S; Schück S; Lieury A; Allain H
    Dement Geriatr Cogn Disord; 1999; 10(2):172-80. PubMed ID: 10026393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristic clinical aspects of Parkinson patients with intellectual impairment.
    Piccirilli M; Piccinin GL; Agostini L
    Eur Neurol; 1984; 23(1):44-50. PubMed ID: 6714277
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Profile of the visual memory test scores of patients with parkinsonism].
    Villardita C; Smirni P; Le Pira F; Barbagallo G; Sciacca A
    Acta Neurol (Napoli); 1981 Feb; 3(1):204-11. PubMed ID: 7246293
    [No Abstract]   [Full Text] [Related]  

  • 57. Serial cognitive profiles in levodopa-induced hypersexuality.
    Harvey NS
    Br J Psychiatry; 1988 Dec; 153():833-6. PubMed ID: 3256388
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Modification of disturbed visual-spatial performance in patients with Parkinson's disease by treatment with L-dopa].
    Jacobi P; Schneider E; Gundelsheimer W; Fischer PA
    Nervenarzt; 1974 Nov; 45(11):588-94. PubMed ID: 4453348
    [No Abstract]   [Full Text] [Related]  

  • 59. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
    Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
    Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):634-7. PubMed ID: 8648329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.